Rush Copley Medical Center

Patient Safety - Central Line Associated Bloodstream Infections (CLABSIs)

Central Line Associated Bloodstream Infections (CLABSIs)

Presented below are annual central line-associated bloodstream infections (CLABSIs) occurring in critical care units, also known as intensive care units (ICUs). ICU-specific summary data for CLABSI are provided using the Standardized Infection Ratio(SIR) . Statewide summaries of CLABSI data arranged by ICU type and hospital are also included.

Export

Statistical Significance

Statistically significantly better than the national average or performing at the best possible rate

Not statistically significantly better or worse than the national average

Statistically significantly worse than the national average

Key	Description
38	Exempt: No Licensed PICU Beds
42	Complete Reporting: Zero infections, but too few central line days to calculate a precise SIR
43	Complete Reporting: Zero infections, but too few central line days to calculate a precise SIR
44	Complete Reporting: Too few central line days to calculate a precise SIR
117	Complete Reporting: Zero infections. Number of reported events is not significantly different than predicted
169	Exempt: No Licensed ICU Beds

Adult CLABSI

Pediatric CLABSI

Ped. CLABSI Measure	Result	SIR
Pediatric Medical-Surgical ICU Q1 2019 - Q4 2019 Result N/A infections, N/A central-line days ¹⁶⁹ Rating SIR: N/A ¹⁶⁹	N/A infections, N/A central-line days ¹⁶⁹	N/A ¹⁶⁹
Description Central Line-associated Bloodstream Infection (CLABSI) data in the Medical-Surgical Pediatric ICU summarized as a Standardized Infection Ratio. Historical Data
Measure	Result	Rating
Q1 2018 - Q4 2018 Result N/A infections, N/A central-line days ¹⁶⁹ Rating SIR: N/A ¹⁶⁹	N/A infections, N/A central-line days ¹⁶⁹	N/A ¹⁶⁹
Q1 2017 - Q4 2017 Result N/A infections, N/A central-line days ¹⁶⁹ Rating SIR: N/A ¹⁶⁹	N/A infections, N/A central-line days ¹⁶⁹	N/A ¹⁶⁹
Q1 2016 - Q4 2016 Result N/A infections, N/A central-line days ³⁸ Rating SIR: N/A ³⁸	N/A infections, N/A central-line days ³⁸	N/A ³⁸
Q1 2015 - Q4 2015 Result N/A infections, N/A central-line days ³⁸ Rating SIR: N/A ³⁸	N/A infections, N/A central-line days ³⁸	N/A ³⁸
Q1 2014 - Q4 2014 Result N/A infections, N/A central-line days ³⁸ Rating SIR: N/A ³⁸	N/A infections, N/A central-line days ³⁸	N/A ³⁸
Q1 2013 - Q4 2013 Result N/A infections, N/A central-line days ³⁸ Rating SIR: N/A ³⁸	N/A infections, N/A central-line days ³⁸	N/A ³⁸
Q1 2012 - Q4 2012 Result N/A infections, N/A central-line days ³⁸ Rating SIR: N/A ³⁸	N/A infections, N/A central-line days ³⁸	N/A ³⁸
Q1 2011 - Q4 2011 Result N/A infections, N/A central-line days ³⁸ Rating SIR: N/A ³⁸	N/A infections, N/A central-line days ³⁸	N/A ³⁸
Q1 2010 - Q4 2010 Result N/A infections, N/A central-line days ³⁸ Rating SIR: N/A ³⁸	N/A infections, N/A central-line days ³⁸	N/A ³⁸
Q1 2010 - Q2 2010 Result N/A infections, N/A central-line days ³⁸ Rating SIR: 0.00 ³⁸	N/A infections, N/A central-line days ³⁸	0.00 ³⁸

NICU CLABSI

Illinois Hospital Report Card

and Consumer Guide to Health Care

Rush Copley Medical Center

Patient Safety - Central Line Associated Bloodstream Infections (CLABSIs)

Central Line Associated Bloodstream Infections (CLABSIs)

Statistical Significance

Adult CLABSI

Description

Historical Data

Pediatric CLABSI

Description

Historical Data

NICU CLABSI

Description

Historical Data

Adult CLABSI Measure	Result	SIR
Adult Medical/Surgical ICU Q1 2024 - Q4 2024 Result 2 infections, 1941 central-line days Rating SIR: 0.91	2 infections, 1941 central-line days	0.91
Description Central Line-associated Bloodstream Infection data in the Adult Medical/Surgical ICU summarized as a Standardized Infection Ratio. Historical Data
Measure	Result	Rating
Q1 2023 - Q4 2023 Result 0 infections, 1920 central-line days Rating SIR: 0.00	0 infections, 1920 central-line days	0.00
Q1 2022 - Q4 2022 Result 1 infections, 2430 central-line days Rating SIR: 0.37	1 infections, 2430 central-line days	0.37
Q1 2021 - Q4 2021 Result 4 infections, 2699 central-line days Rating SIR: 1.31	4 infections, 2699 central-line days	1.31
Q1 2020 - Q4 2020 Result 2 infections, 2660 central-line days Rating SIR: 0.67	2 infections, 2660 central-line days	0.67
Q1 2019 - Q4 2019 Result 1 infections, 1944 central-line days Rating SIR: 0.46	1 infections, 1944 central-line days	0.46
Q1 2018 - Q4 2018 Result 0 infections, 2093 central-line days ¹¹⁷ Rating SIR: 0.00 ¹¹⁷	0 infections, 2093 central-line days ¹¹⁷	0.00 ¹¹⁷
Q1 2017 - Q4 2017 Result 0 infections, 1731 central-line days ¹¹⁷ Rating SIR: 0.00 ¹¹⁷	0 infections, 1731 central-line days ¹¹⁷	0.00 ¹¹⁷
Q1 2016 - Q4 2016 Result 0 infections, 2020 central-line days ¹¹⁷ Rating SIR: 0.00 ¹¹⁷	0 infections, 2020 central-line days ¹¹⁷	0.00 ¹¹⁷
Q1 2015 - Q4 2015 Result 4 infections, 2058 central-line days Rating SIR: 0.93	4 infections, 2058 central-line days	0.93
Q1 2014 - Q4 2014 Result 0 infections, 1763 central-line days Rating SIR: 0.00	0 infections, 1763 central-line days	0.00
Q1 2013 - Q4 2013 Result 0 infections, 2407 central-line days Rating SIR: 0.00	0 infections, 2407 central-line days	0.00
Q1 2012 - Q4 2012 Result 2 infections, 2333 central-line days Rating SIR: 0.41	2 infections, 2333 central-line days	0.41
Q1 2011 - Q4 2011 Result 0 infections, 2369 central-line days Rating SIR: 0.00	0 infections, 2369 central-line days	0.00
Q1 2010 - Q4 2010 Result 1 infections, 2225 central-line days Rating SIR: 0.21	1 infections, 2225 central-line days	0.21
Q1 2009 - Q4 2009 Result 1 infections, 1967 central-line days Rating SIR: 0.24	1 infections, 1967 central-line days	0.24
Q1 2009 - Q2 2009 Result 1 infections, 995 central-line days Rating SIR: 1.01	1 infections, 995 central-line days	1.01

NICU CLABSI Measure	Result	SIR
Level II/III Neonatal ICU Q1 2023 - Q4 2023 Result 2 infections, 541 central-line days Rating SIR: N/A	2 infections, 541 central-line days	N/A
Description Central Line-associated Bloodstream Infection data in the Level II/III Neonatal ICU summarized as a Standardized Infection Ratio. Historical Data
Measure	Result	Rating
Q1 2022 - Q4 2022 Result 1 infections, 598 central-line days ⁴⁴ Rating SIR: N/A ⁴⁴	1 infections, 598 central-line days ⁴⁴	N/A ⁴⁴
Q1 2021 - Q4 2021 Result 2 infections, 505 central-line days ⁴⁴ Rating SIR: N/A ⁴⁴	2 infections, 505 central-line days ⁴⁴	N/A ⁴⁴
Q1 2020 - Q4 2020 Result 1 infections, 542 central-line days ⁴⁴ Rating SIR: N/A ⁴⁴	1 infections, 542 central-line days ⁴⁴	N/A ⁴⁴
Q1 2019 - Q4 2019 Result 1 infections, 636 central-line days ⁴⁴ Rating SIR: N/A ⁴⁴	1 infections, 636 central-line days ⁴⁴	N/A ⁴⁴
Q1 2018 - Q4 2018 Result 0 infections, 888 central-line days ¹¹⁷ Rating SIR: 0.00 ¹¹⁷	0 infections, 888 central-line days ¹¹⁷	0.00 ¹¹⁷
Q1 2017 - Q4 2017 Result 0 infections, 316 central-line days ⁴² Rating SIR: N/A ⁴²	0 infections, 316 central-line days ⁴²	N/A ⁴²
Q1 2016 - Q4 2016 Result 1 infections, 1111 central-line days Rating SIR: 0.53	1 infections, 1111 central-line days	0.53
Q1 2015 - Q4 2015 Result 0 infections, 416 central-line days ¹¹⁷ Rating SIR: 0.00 ¹¹⁷	0 infections, 416 central-line days ¹¹⁷	0.00 ¹¹⁷
Q1 2014 - Q4 2014 Result 0 infections, 548 central-line days ¹¹⁷ Rating SIR: 0.00 ¹¹⁷	0 infections, 548 central-line days ¹¹⁷	0.00 ¹¹⁷
Q1 2013 - Q4 2013 Result 4 infections, 928 central-line days Rating SIR: 1.48	4 infections, 928 central-line days	1.48
Q1 2012 - Q4 2012 Result 0 infections, 854 central-line days ⁴³ Rating SIR: 0.00 ⁴³	0 infections, 854 central-line days ⁴³	0.00 ⁴³
Q1 2011 - Q4 2011 Result 1 infections, 1009 central-line days Rating SIR: 0.34	1 infections, 1009 central-line days	0.34
Q1 2010 - Q4 2010 Result 0 infections, 763 central-line days ⁴³ Rating SIR: 0.00 ⁴³	0 infections, 763 central-line days ⁴³	0.00 ⁴³
Q1 2010 - Q2 2010 Result 0 infections, 285 central-line days Rating SIR: 0.00	0 infections, 285 central-line days	0.00